Patent · US Expired

5-substituted isoquinoline derivatives

US7094789B2 · kind B2 · utility

5Cited by
10References
50Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 2003
Grant dateAug 22, 2006
Priority date
Expiry dateNov 27, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D217/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound represented by the following formula (1) or a salt thereof:wherein R1 represents hydrogen atom, a halogen atom and the like; R2 represents hydrogen atom, a halogen atom, a C1-6 alkyl group and the like; and R3 represents —O—X—C(A1)(A11)-C(A2)(A21)-N(A31)(A3) (X represents propylene group etc., A11 and A21 represent hydrogen atom, or a C1-6 alkyl group, A31 represents a C1-6 alkyl group substituted with hydroxyl group, or hydrogen atom, and A1, A2, and A3 represent hydrogen atom, a C1-6 alkyl group and the like) and the like, which has an inhibitory activity on the phosphorylation of myosin regulatory light chain, and is useful for treatment of diseases relating to contraction of various cells and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.